Laura Greco, a seasoned attorney and mother of two young boys, was diagnosed in February 2015 with stage 3 non-small cell lung cancer at the age of 40, as a result of a freak car accident. About a year after finishing multiple lines of chemotherapy, radiation, and surgery, she experienced a metastatic recurrence in October 2016. She started Alectinib, a targeted therapy for her ALK fusion, and is still on her first line TKI.
Laura has given up her law practice in order to spend more time with her children and husband, focus on her health, and become a lung cancer advocate. Her many advocacy accomplishments include:
- Co-founder of the Life and Breath (LAB) movement, a grassroots lung cancer organization. She organized and led two rallies on Capitol Hill and assisted in coordination of lung cancer advocacy efforts.
- Past leader and Co-Founder of Executive Outreach Team of ALK Positive in which she spearheaded fundraising and grant review process in 2018 resulting in the grant of three $200,000 awards for ALK research.
- Volunteers with the Lungevity Foundation, Lung Cancer Alliance, and the Lung Cancer Foundation of America.
- Speaker on lung cancer issues in numerous television, print media, and radio venues.
- Speaker to patient groups at the Dana Farber Cancer Institute and the Brigham and Women’s Hospital.
- International Speaker for various pharmaceutical companies.
- Three-time consumer reviewer for the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP) for lung cancer. (2016-2018)
- Programmatic Panel member for Department of Defense’s Congressionally Directed Medical Research Program (CDMRP) for lung cancer (2019-Present)
Twitter: @lgreco_ny http://Twitter.com/lgreco_ny